Rheumatic fever is an autoimmune disorder caused by a prior streptococcal infection of the throat or skin. It is characterized by inflammation of the heart (carditis), joints (arthritis), brain (chorea), or subcutaneous tissue (erythema marginatum or subcutaneous nodules). Diagnosis is based on the Jones criteria of symptoms occurring 1-5 weeks after strep infection, plus evidence of a recent strep infection. Treatment involves antibiotics to prevent recurrent strep infections, along with aspirin or steroids for arthritis and carditis. Long-term antibiotic prophylaxis is also needed to prevent future episodes of rheumatic fever.
3. Disease overall view
Rheumatic fever is a systemic autoimmune
disorder related to prior streptococcal infection
The development of rheumatic fever is preceded by the
upper respiratory tract infection (tonsillitis or pharyngitis)
with Group A β-hemolytic streptococci.
3
4. Disease overall view
Autoimmune mediated by: Antigenic similarity: Abs
formed against streptococcal Ags react with native
human tissue antigens(autoimmune tissue
damage)
The latent period between streptococcal infection
& onset of RF is 1-5 wks.
4
5. Precipitating factors
Age: between 5-15 yrs.
Sex: equal except for rheumatic chorea (common
in females).
Socio-economic factors: common in developing
countries &low social classes (overcrowding &bad
hygiene).
Recurrent and severe recent strept. infections
5
6. Diagnosis
Jone’s criteria
Polyarthritis: w/ low grade fever, large joints,
migratory - often 1 at a time, No permanent
dysfunction. (>75%)
Carditis, pericarditis, cardiomegaly, or
valvulitis (the most serious manifestation &
often results in permanent damage).
(~50%)
plus
Evidence of a recent group A Strep infection
6
7. Diagnosis
Jone’s criteria
Chorea: late occurrence, 1- 6 months after
the infection, self-limiting, resolves in 1- 3
months. (~30%)
plus
Evidence of a recent group A Strep infection
7
8. Diagnosis
Jone’s criteria
Erythema Marginatum:
“classic” truncal rash, migratory - appears &
disappears within hours.
(pink rash – irregular red edges serpiginous
borders– clear center) (~10%)
plus
Evidence of a recent group A Strep infection
8
9. Diagnosis
Jone’s criteria
Subcutaneous Nodules:
Late occurrence ( months after infection)
Painless small nodules over bony
prominences:
Elbows
Knees
spine. (1- 2%)plus
Evidence of a recent group A Strep infection
9
10. Diagnosis
Jone’s criteria
Fever
Arthralgia (mild pain without objective
findings): Can only be considered without
finding of arthritis
Elevated acute-phase reactants: ESR, C-
reactive protein.
plus
Evidence of a recent group A Strep infection
10
11. Diagnosis
Anti streptococcal Abs are investigated:
ASO
Anti-deoxy-ribonuclease (DNAse) B
Anti-hyaluronidase
Heart reactive antibodies
Tropomyosin is elevated in acute rheumatic
fever.
plus
Evidence of a recent group A Strep infection
11
12. Diagnosis
Diagnosis with rheumatic fever if you meet two
major criteria, or one major and two minor criteria,
and have signs that you've had a previous strep
infection.
12
Work ups
15. Management
Prevention
1ry prevention by treating Strep. Pharyngitis:
The penicillin is the drug of choice because:
Narrow spectrum of activity
Long standing efficacy
Low cost
15
20. Management
Adverse effect of penicillins
Site of injection:
Pain with IM route, inflammation at IV-site
Blood:
Hemolytic anemia, thrombocytopenia,
neutropenia
20
21. Management
In case of penicillin allergy use:
Oral erythromycin:
(20-40 mg/kg/day)(2-4 times/day)(up to
1gm/day) for 10 days.
Newer macrolides
Oral cephalosporins
21
24. Management
2ry prevention starts after diagnosis of RF:
Rheumatic Fever requires “continuous” prophylactic
antibiotics due to:
1. Increased “susceptibility” to recurrences
2. Increased “severity” of recurrences
3. “Asymptomatic nature” of Strep. Infections.
24
32. Management32
Treatment of:
Carditis === severe
case < use prednisolone
2 mg/kg /day 2-4 divided doses (max 60mgm /day )
2-3 wks [ ESR < 30mm / 1hr ]
Taper off 5 mg / 3 days
Add - Aspirin 75 mgm / kg / day x 8 -10 weeks
33. Management33
Clinical Severity
Arthralgia or mild
arthritis; no carditis
Mod./severe arthritis;
no carditis OR carditis
without failure
Treatment
Analgesics only
Aspirin 100 mg/kg/d
with meals for 3 wk
(or longer up to 6 wk);
then taper gradually
over 6 wk
34. Management34
Clinical Severity
Carditis with failure;
with or without joint
manifestation
Treatment
Prednisone 40-60
mg/d, if necessary;
after 3 wk, slow
tapering over 3 wk,
continue aspirin for 4
wk after d/c of
prednisone.
35. Management35
Treatment of:
Rheumatic chorea
Haloperidol : initial dose 0.5 to 1 mg and 0.5
is added every 3 days for Maximal effect or
until a maximal dose of 5 mg/ day
Sodium valproate: (15 to 20 mg/kg per day)
is also effective.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 20-25 mg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.
Dosage may be adjusted according to patient response, tolerance, and serum salicylate levels (therapeutic range is 250 to 400 mcg/mL for rheumatic fever). Generally after 1 to 2 weeks, the dosage is decreased to approximately 60 to 70 mg/kg/day and given for an additional 1 to 6 weeks or longer if necessary, then gradually withdrawn over 1 to 2 weeks. An appropriate course of antibiotic therapy should be initiated at the time of diagnosis of rheumatic fever.